A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Relapsing/Refractory Multiple Sclerosis
Clinical trial NCT07748637 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07748637
- Sponsor
- Daishi Tian
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-15
- Primary completion
- 2031-07-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.